Home › Multipel myeloom › Californië › Santa Monica
Multipel myeloom klinische studies in Santa Monica, CA
8 studies voor Multipel myeloom zoeken deelnemers op locaties in en rond Santa Monica (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RekruterenFase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mijl verwijderd
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekruterenFase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mijl verwijderd
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruterenFase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mijl verwijderd
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mijl verwijderd
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruterenFase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekruterenFase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mijl verwijderd
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruterenFase 3
- GSK Investigational Site, Beverly Hills · 6 mijl verwijderd
Multipel myeloom studies in andere steden
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA42 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Edison, NJ22 studies
Andere studies in Santa Monica
- Niet-kleincellige longkanker45 studies
- Borstkanker28 studies
- Colorectale kanker23 studies
- Kanker (alle vormen)22 studies
- Metastatische kanker19 studies
- Longkanker15 studies
- Eierstokkanker15 studies
- Prostaatkanker15 studies
- Plaveiselcelcarcinoom van hoofd en hals13 studies
- Hartfalen11 studies
- Endometriumkanker10 studies
- Maagkanker9 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.